White Julia
From the Department of Radiation Oncology, The James, Ohio State University Comprehensive Cancer Center.
Am Soc Clin Oncol Educ Book. 2013:40-4. doi: 10.14694/EdBook_AM.2013.33.40.
Breast radiotherapy after lumpectomy is considered standard for nearly all patients with invasive breast cancer and is recommended for many patients after lumpectomy for ductal carcinoma in situ (DCIS). However, there is recognition that lumpectomy alone can achieve optimal cancer control for some patients with invasive breast cancer and DCIS. Patients with breast cancers with lower risk of recurrence are less likely to derive benefit from breast radiotherapy. This review will focus on defining populations of patients with invasive breast cancer and DCIS with a low risk of recurrence post-lumpectomy and the evidence supporting omission of breast radiotherapy post-lumpectomy.
对于几乎所有浸润性乳腺癌患者，保乳术后进行乳房放疗被视为标准治疗方案，对于许多导管原位癌（DCIS）保乳术后的患者也推荐进行放疗。然而，人们认识到，对于一些浸润性乳腺癌和DCIS患者，单纯保乳手术即可实现最佳的癌症控制。复发风险较低的乳腺癌患者从乳房放疗中获益的可能性较小。本综述将重点关注确定保乳术后复发风险较低的浸润性乳腺癌和DCIS患者群体，以及支持保乳术后省略乳房放疗的证据。
